GC Biopharma signs ₩142.1bn Brazil export supply contract
GC Biopharma filed a Brazil export supply contract with BLAU Farmaceutica S.A. worth ₩142.1bn, reported as 8.3% of revenue. The contract period runs from Jun 30, 2023 to Jun 29, 2028.
Key facts
| Contract name | Brazil export supply contract |
|---|---|
| Counterparty | BLAU Farmaceutica S.A. |
| Contract amount | ₩142.1bn |
| % of revenue (as reported) | 8.3% |
| Period start | Jun 30, 2023 |
| Period end | Jun 29, 2028 |
Comparison
| Amount as % of FY2025 revenue (calculated) | 7.1% |
|---|---|
| Revenue 2025 | ₩2.0tn |
| Revenue 2024 | ₩1.7tn |
| Revenue 2023 | ₩1.6tn |
Context
By our calculation, the contract amount is 7.1% of FY2025 revenue.
Key metrics
Supply contracts
| Supply contracts, last 12 months | ₩59.2bn |
|---|---|
| Supply contracts vs prior-year revenue | 3.0% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Related filings
Source: DART (Financial Supervisory Service) · Original filing on DART ↗